source
- Recon: FDA identifies four deaths in Newron schizophrenia drug trials; Dutch court blocks subcutaneous Keytruda in eight Europea...Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.raps · 12d ago↗ source
- EMA to revise pharmacogenomics guideline as MHRA adopts AI framework for medical devicesThe European Medicines Agency’s Committee for Medicinal Products for Human Use is preparing a major revision of its 2018 guideline on good pharmacogenomic practices. Regulators say the rapid advan…